ST-BRUNO-DE-MONTARVILLE, Québec, 23 juill. 2025 (GLOBE NEWSWIRE) -- À nouveau, cet automne, les agriculteurs de cinq provinces pourront éliminer de façon sécuritaire, les pesticides agricoles périmés et les médicaments périmés destinés au bétail et aux chevaux dans le cadre du programme de collecte d’AgriRÉCUP.
SAN FRANCISCO, July 22, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating a data breach that led to unauthorized access to customer information held...
CHARLOTTE, N.C., July 22, 2025 /PRNewswire/ -- The Board of Directors of Albemarle Corp. (NYSE: ALB) announced today that it declared a quarterly common...
Vastned NV has received on 18 July 2025 a transparency notification dated 18 July 2025, which indicates that Wistersingel I B.V., as a result of the acquisition of shares on 17 July 2025, now holds more than 10% of the voting rights of Vastned NV. Westersingel I B.V. has thus crossed the 10% threshold (upward).
MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 June 2025 (Q2 2025). All figures are in USD unless stated otherwise.
COPENHAGEN, Denmark, July 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for licensure of the single-dose, virus-like particle (VLP) chikungunya vaccine candidate, CHIKV VLP, for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older. The application screening acceptance by the Directorate confirms that the New Drug Submission is complete and begins a standard review procedure, potentially supporting approval of the vaccine in the first half of 2026.
AUGA group, AB entity under restructuring (code 126264360, registered office at Konstitucijos pr. 21C, Vilnius, hereinafter referred to as the “Company”), by the initiative and decision of the Board, is convening a General meeting of shareholders on August 12, 2025, at 10:00 a.m., where the Company’s shareholders will vote on the approval of the Company’s draft restructuring plan, hereinafter referred to as the “Meeting”.
LONDON, July 18, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection...
NEWTOWN, Pa., July 18, 2025 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Anne Arundel...
ACHESON, Alberta, July 17, 2025 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA.TO/NYSE:NOA) announced today that it will release its financial results for the second quarter ended June 30, 2025, on Wednesday, August 13, 2025, after markets close. Following the release of its financial results, NACG will hold a conference call and webcast on Thursday, August 14, 2025, at 7:00 a.m. Mountain Time (9:00 a.m. Eastern Time).